Curative Biotechnology, Inc. Stock Other OTC
Equities
CTYX
US20786Q2093
Biotechnology & Medical Research
Sales 2020 | - | Sales 2021 | - | Capitalization | 29.41M 40.51M |
---|---|---|---|---|---|
Net income 2020 | -4M -5.51M | Net income 2021 | -5M -6.89M | EV / Sales 2020 | - |
Net Debt 2020 | 399K 550K | Net cash position 2021 | 670K 923K | EV / Sales 2021 | - |
P/E ratio 2020 |
-2.11
x | P/E ratio 2021 |
-1.44
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 99.95% |
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 21-02-10 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 22-05-11 |
Theresa Heah
BRD | Director/Board Member | 46 | 03-30 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |